Historical values vs. Current blood eosinophils in patients with severe uncontrolled asthma: predictive ability of future risks. ENEAS II study.
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: SPANISH LUNG FOUNDATION - RESPIRA
- Execution start: 17/09/2020
- End of execution: 30/04/2021
- PI: BERNARDINO ALCAZAR NAVARRETE